January 2025 Newsletter
Safe Biologics
MARCH 10, 2025
The consequences of the IRAs small molecule penalty, which limits the time manufacturers have to recoup investments in simpler small molecule drugs like pills, are already being felt. Small molecule drugs make up over 90% of prescriptions filled in the U.S. PBM Reform: Could 2025 Finally See a Long-Awaited Overhaul?
130 
Let's personalize your content